| Home Forums |
|
|||||||
| MDS Myelodysplastic syndromes |
 |
|
|
Thread Tools | Search this Thread |
|
#1
Tue May 22, 2012, 05:42 PM
|
|||
|
|||
|
Velcade-Cytarabine Combo for Higher-Risk MDS
From the MDS Beacon
Velcade-Cytarabine Combination Shows Promise For Certain Higher-Risk MDS Patients by Jessica Langholtz According to a recent Phase 1/2 study conducted in Europe, the combination of Velcade and cytarabine may be effective and safe in higher-risk myelodysplastic syndromes patients who have not been previously treated. In addition, the combination showed activity in patients with unfavorable chromosomal abnormalities. Specifically, 13 percent of these patients responded, which the investigators describe as notable, since no patients with these types of chromosomal abnormalities responded in previous studies testing cytarabine alone. For the rest, see the article at MDS Beacon. 
|
|
| Thread Tools | Search this Thread |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| MDS - VA assigns diagnostic code 7725 | Tommy Daniels | MDS | 4 | Sun Jan 22, 2017 03:51 PM |
| cytarabine for high risk mds patients | rob k | MDS | 0 | Thu Sep 13, 2012 12:33 PM |
| Under 60 and Have Low Risk MDS? Read this. | Greg H | Drugs and Drug Treatments | 5 | Sun Sep 18, 2011 02:58 PM |
| The lower risk MDS patient at risk of rapid progression | akita | MDS | 0 | Mon Dec 27, 2010 04:28 AM |
